None listed
Conditions
Interventions
Drug : There are currently no published data on the treatment outcomes of metastatic backliders, particularly colon n patients. Given that there is a lack of high level of evidence supporting any type
Sponsors
Samsung Medical Center
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: *Organically identified endocrine tumors that are highly or moderately fragmented. WHO 2010 Grade 1 or 2 * Age - over 20 * disease measurable by RECIST v 1.0 * In case the primary tumor is located in the back and the colon. * Non-functional or functional neuroendocrine tumors * Non-ablationable local progressive or metastatic disease
Exclusion criteria
Exclusion criteria: * Any previous point in time has been subject to full-body therapy, including interferon, chemotherapy, Peptide Receptor Radionuclide Therapy , chemotherapy, or a similar Somatostatin (unless received more than 6 months or over <15 days). * Multiple endocrine tumors * Prior to cancer, patients with cervical cervical cervical cervical cancer or intravenous cancer of the uterus or basal cell skin cancer or other cancer patients who have been in an untreated condition for five years. * Front bars, intermediate spears and pancreas and undetected neuroendocrine tumors.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Inactive survival | — |
Secondary
| Measure | Time frame |
|---|---|
| Total survival | — |
Countries
Korea, Republic of
Contacts
Public ContactYoungsuk park
Samsung Medical Center
Outcome results
None listed